Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.88M Hold
14,634
0.9% 30
2026
Q1
$1.76M Sell
14,634
-947
-6% -$109K 0.96% 28
2025
Q4
$1.64M Sell
15,581
-414
-3% -$38.9K 0.89% 30
2025
Q3
$1.34M Sell
15,995
-300
-2% -$24.7K 0.76% 29
2025
Q2
$1.29M Sell
16,295
-100
-0.6% -$7.95K 0.83% 28
2025
Q1
$1.47M Buy
16,395
+98
+0.6% +$9.15K 1.03% 26
2024
Q4
$1.62M Sell
16,297
-849
-5% -$87.5K 1.12% 25
2024
Q3
$1.95M Sell
17,146
-285
-2% -$33.9K 1.3% 21
2024
Q2
$2.16M Sell
17,431
-1,072
-6% -$138K 1.56% 16
2024
Q1
$2.44M Buy
18,503
+2,081
+13% +$257K 1.82% 15
2023
Q4
$1.79M Buy
16,422
+275
+2% +$28.5K 1.41% 21
2023
Q3
$1.66M Sell
16,147
-855
-5% -$92.2K 1.55% 18
2023
Q2
$1.96M Sell
17,002
-1,177
-6% -$134K 1.77% 13
2023
Q1
$1.93M Sell
18,179
-1,025
-5% -$111K 1.88% 12
2022
Q4
$2.13M Buy
19,204
+3,238
+20% +$331K 2.24% 10
2022
Q3
$1.38M Hold
15,966
1.6% 16
2022
Q2
$1.46M Buy
15,966
+1,032
+7% +$91.5K 1.64% 14
2022
Q1
$1.23M Buy
14,934
+500
+3% +$39.4K 1.27% 21
2021
Q4
$1.11M Buy
+14,434
New +$1.15M 1.03% 27

Other funds holding MRK

Meridian Financial's MRK Position: Q2 2026 in Review

Meridian Financial held its Merck (MRK) position steady in Q2 2026 at 14,634 shares worth $1.88M. The position accounts for 0.9% of the portfolio, ranked #30.

Meridian Financial first reported a position in MRK in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.44M in Q1 2024. 3,824 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Meridian Financial held 14,634 shares of Merck worth $1.88M as of Q2 2026.
  • Meridian Financial left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.9% of Meridian Financial's portfolio in Q2 2026, its #30 holding.
  • Meridian Financial first reported a position in Merck in Q4 2021 and has held it in 19 quarters since.
  • Meridian Financial's Merck position peaked at $2.44M in Q1 2024.
  • 3,824 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Meridian Financial's 13F filing for Q2 2026, filed 22 Jul 2026.